Back to Journals » Drug Design, Development and Therapy » Volume 16
Sulfasalazine Inhibits Inflammation and Fibrogenesis in Pancreas via NF-κB Signaling Pathway in Rats with Oxidative Stress-Induced Pancreatic Injury [Retraction]
Wang Y, Tian F, Yan M, et al. Drug Des Devel Ther. 2016;10:1743–1751.
At the authors request, the Editor and Publisher of Drug Design, Development and Therapy wish to retract the published article. Previous concerns had been raised to the authors regarding the alleged duplication of images in Figures 1A-b and 1A-c and a corrigendum had been published. More recently, concerns have also been raised to the authors regarding the alleged duplication of images between Figure 2A-b and 2A-e. In addition, there were also concerns raised regarding the duplication of certain features between several images from Figures 2 and 3. The journal wishes to recognize that these particular concerns were introduced during the publication process and were not introduced by the authors.
However, in relation to the duplication of images between Figure 2A-b and 2A-e, the authors have acknowledged this. The authors were able to provide original data to the journal, but it was unable to support the integrity of the research and the authors requested to retract the article and the Editor agreed with this.
Our decision-making was informed by our policy on publishing ethics and integrity and the COPE guidelines on retraction.
The retracted article will remain online to maintain the scholarly record, but it will be digitally watermarked on each page as “Retracted”.
This retraction relates to this paper
© 2022 The Author(s). This work is published and licensed by Dove Medical Press Limited. The
full terms of this license are available at https://www.dovepress.com/terms.php
and incorporate the Creative Commons Attribution
- Non Commercial (unported, v3.0) License.
By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted
without any further permission from Dove Medical Press Limited, provided the work is properly
attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms.